Cancer: Research

Business, Innovation and Skills written question – answered on 26th June 2012.

Alert me about debates like this

Photo of Jeremy Lefroy Jeremy Lefroy Conservative, Stafford

To ask the Secretary of State for Business, Innovation and Skills what funding his Department has allocated for research and development of genetic therapies to treat cancer in children in (a) 2011-12, (b) 2012-13, (c) 2013-14, (d) 2014-15 and (e) 2015-16.

Photo of David Willetts David Willetts Minister of State (Universities and Science)

The Medical Research Council (MRC) is one of the main agencies through which the Government supports medical and clinical research, including cancer research.

The MRC does not normally allocate funding for specific disease areas and future research funding is dependent on the quality and strategic relevance of proposals submitted by the research community and is determined through peer review. Information on future funding that may be awarded for this area is not available. However, the MRC would welcome proposals which may support research leading to the development of genetic therapies to treat cancer in children. This may include fundamental research through to pre-clinical development, and early clinical testing of novel therapeutics, devices and diagnostics.

In 2010 the MRC's overall expenditure on cancer was £107.9 million(1). This includes a broad portfolio of site-specific and general underpinning cancer research some of which will be relevant to cancer in children. The MRC does not hold a breakdown of expenditure on research directly relating to research and development of genetic therapies to treat cancer in children. It would not be possible to undertake the necessary analysis in the time available.

(1) Source—National Cancer Research Institute CaRD

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.